SCHEMBL7926543

SCHEMBL7926543

CCCCCCCOc1cc2ccc(Br)cc2cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.39
FAAH O00519 2/20 0.39
CNR1 P21554 1/20 0.39
RARA P10276 2/20 0.38
RARB P10826 2/20 0.38
RARG P13631 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NR1I2 O75469 1/20 0.38
LMNA P02545 1/20 0.38
PGR P06401 1/20 0.38
HSPD1 P10809 1/20 0.38
GOT1 P17174 1/20 0.38
GLRA1 P23415 1/20 0.38
BLM P54132 1/20 0.38
HSPE1 P61604 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9331929 0.87 CNR2 (0.42) CNR2FAAHCNR1RARARARB
SCHEMBL7691267 0.86 IKBKB (0.40) RARARARBRARGMEN1KMT2A
SCHEMBL7920649 0.84 CNR2 (0.39) CNR2FAAHCNR1RARARARB
SCHEMBL12309820 0.82 LMNA (0.41) CNR2FAAHCNR1RARARARB
SCHEMBL9763614 0.80 RARA (0.49) CNR2FAAHRARARARBRARG
SCHEMBL7689456 0.80 IKBKB (0.49) RARARARBRARGMEN1KMT2A
SCHEMBL7521122 0.79 MEN1 (0.61) RARARARBRARGMEN1KMT2A
SCHEMBL7932567 0.78 TRPV6 (0.43) CNR2FAAHCNR1MEN1KMT2A
SCHEMBL8459010 0.78 LMNA (0.43) CNR2FAAHCNR1RARARARB
SCHEMBL7920651 0.78 RARB (0.54) CNR2FAAHCNR1RARARARB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6225328-B1 FOR THERAPY OF DISORDERS OR AILMENTS RELATED TO AN OVERREGULATION OF RETINOIC ACID RECEPTORS AND/OR TO HYPERVIAMINOSIS A CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2001-05-01 US disclosed
US-5952382-A INHIBITING THE BIOLOGICAL EFFECTS OF AN OVERREGULATION OF RETINOID ACID RECEPTORS AND/OR OF A HYPERVITAMINOSIS A; TREATING SKIN DISORDER, EYE VISION DEFECTS, SKIN AGING CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1999-09-14 US disclosed
EP-0740937-A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1996-11-06 EP disclosed